Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -25.80K | -417.40K | -269.10K | -239.30K | -319.70K |
| Total Depreciation and Amortization | -- | -64.00K | 64.00K | 179.70K | 51.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.00K | -82.50K | 82.50K | -823.30K | 37.20K |
| Change in Net Operating Assets | -- | 24.10K | -24.10K | 1.44M | 137.50K |
| Cash from Operations | 2.10K | -539.80K | -146.80K | 552.40K | -93.30K |
| Capital Expenditure | -- | -- | -- | -567.80K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -567.80K | 0.00 |
| Total Debt Issued | -- | -194.00K | 194.00K | 161.50K | 160.00K |
| Total Debt Repaid | -- | 80.20K | -80.20K | -108.50K | -57.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -684.90K | 684.90K | -- | -- | -- |
| Cash from Financing | -684.90K | 571.10K | 113.70K | 53.00K | 102.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 655.20K | 3.30K | -- | -- | -- |
| Net Change in Cash | -27.50K | 34.70K | -33.00K | 37.60K | 9.50K |